Perrigo Launches Generic BenzaClin Gel
BenzaClin Gel is indicated for the topical treatment of acne vulgaris. It combines clindamycin, a lincosamide antibiotic, and benzoyl peroxide, an antibacterial/keratolytic. The clindamycin and benzoyl peroxide components individually have been shown to have in vitro activity against Propionibacterium acnes, an organism associated with acne vulgaris.
Perrigo has begun shipment of Clindamycin Phosphate 1% and Benzoyl Peroxide Gel 5%.
For more information call (866) 634-9120 or visit Perrigo.com.